How relevant is secondary leukaemia for initial treatment selection in hodgkin's disease?
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (10) , 1441-1447
- https://doi.org/10.1016/0959-8049(94)00284-c
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Advances in the treatment of Hodgkinʼs diseaseCurrent Opinion in Oncology, 1992
- Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.BMJ, 1992
- Progress, problems and priorities in quality of life researchEuropean Journal Of Cancer, 1992
- Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.BMJ, 1990
- Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomasCancer, 1990
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseNew England Journal of Medicine, 1987
- Decision AnalysisNew England Journal of Medicine, 1987
- Incidence of Acute Nonlymphocytic Leukemia, Preleukemia, and Acute Myeloproliferative Syndrome up to 10 Years after Treatment of Hodgkin's DiseaseNew England Journal of Medicine, 1982
- Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.BMJ, 1980